基于Ras/Raf-1/ERK信号转导通路调控VEGF的表达探讨活血解毒方对糖尿病大鼠视网膜的影响

目的:观察活血解毒方对糖尿病大鼠视网膜血管形态的影响并探讨其可能的作用机制。方法:一次性腹腔注射链脲佐菌素(Streptozotocin,STZ,65 mg/kg)诱导糖尿病大鼠模型,造模后随机分为模型组和活血解毒方组。另设正常对照组。药物干预12周后,应用视网膜消化铺片法观察视网膜血管形态;应用Western blot法检测视网膜VEGF蛋白的表达,应用Real-Time PCR法检测视网膜VEGF、Ras、Raf-1与ERK mRNA的表达。结果:模型组视网膜毛细血管面积密度及内皮细胞/周细胞比例与较正常组升高(P<0.001),VEGF蛋白及VEGF、Ras、ERKmRNA表达升高(P<0.05),Raf-1mRNA表达升高(P>0.05)。与模型组比较,活血解毒方组视网膜毛细血管面积密度和内皮细胞/周细胞比例降低(P<0.01和P<0.001),VEGF蛋白与VEGF、Ras、Raf-1、ERK mRNA表达下降(P<0.05)。结论:活血解毒方能明显抑制视网膜毛细血管和内皮细胞的增生,其机制可能是通过干预Ras/Raf-1/ERK信号转导通路,下调VEGF在视网膜中的表达,抑制血管新生,从而改善DR。

TTF1调控ERK信号转导通路的作用

[目的]探讨TTF1调控ERK信号转导通路的作用.[方法]建立人肝癌HepG2裸鼠移植瘤模型,取40只随机分为阴性对照组、紫杉醇组、TTF1小剂量组、TTF1中剂量组及TTF1大剂量组,每组各为8只,药物干预21 d后处死裸鼠,采用Western blot技术检测肿瘤组织ERK1/2和p-ERK1/2蛋白表达.[结果]TTF1对人肝癌HepG2裸鼠移植瘤的生长有抑制作用;ERK1/2蛋白表达未见明显变化,p-ERK1/2蛋白表达随着TTF1剂量的升高而减少.[结论]TTF1对肿瘤生长有抑制作用,其机制可能与通过调节ERK信号转导通路有关.

Up-regulation of Ras/Raf/ERK1/2 signaling in the spinal cord impairs neural cell migration, neurogenesis, synapse formation, and dendritic spine development

Background The Ras/Raf/ERK1/2 signaling pathway controls many cellular responses such as cell proliferation, migration, differentiation, and death. In the nervous system, emerging evidence also points to a death-promoting role for ERK1/2 in both in vitro and in vivo models of neuronal death. To further investigate how Ras/Raf/ERK1/2 up-regulation may lead to the development of spinal cord injury, we developed a cellular model of Raf/ERK up-regulation by over- expressing c-Raf in cultured spinal cord neurons （SCNs） and dorsal root ganglions （DRGs）.